BINGO: Bridging Knowledge, Increasing Awareness
1 other identifier
interventional
54
1 country
1
Brief Summary
The U.S. population is becoming more diverse, but minority groups are still significantly underrepresented in cancer clinical trials. This disparity limits our understanding of how treatments work across different populations. Efforts like the 21st Century Cures Act aim to improve inclusion, but challenges persist due to historical mistrust and complex barriers in healthcare. To address these issues, Penn State Health is using a fun and educational approach called "BINGO" to engage the African American/Black community in Dauphin and surrounding counties. Led by the PSCI Diversity Navigator, these BINGO games will provide information about cancer and clinical trials in a relaxed setting. The goal is to build trust, increase awareness, and ultimately improve participation of underrepresented groups in clinical trials. Through this initiative, they hope to connect participants with needed healthcare services and gather feedback to tailor future trials to community needs. This approach aims to foster collaboration between minority communities and the healthcare system, ensuring that clinical trials reflect the diversity of the population they aim to serve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2024
CompletedFirst Posted
Study publicly available on registry
July 16, 2024
CompletedStudy Start
First participant enrolled
October 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2025
CompletedMarch 23, 2026
January 1, 2026
1.1 years
July 11, 2024
March 18, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Feasibility Measure
Percentage of Participants Attending a Complete Bingo Game Session and Completing Pre- and Post-Test Surveys.
one year
Utility Measure
Pre- and post-test scores on knowledge-based questions will be compared to measure the effectiveness of the educational content.
one year
Engagement Measure
Participant engagement will be evaluated using a 5-point Likert scale, with the percentage of participants who "strongly agree or agree" that Bingo game was engaging being the primary measure.
one year
Study Arms (1)
Bingo Educational Intervention
EXPERIMENTALSingle-arm, interventional study where all participants will engage in the Bingo game as an educational intervention.
Interventions
The intervention involves Bingo games designed to educate African American/Black community members about cancer and clinical trials. During each game, educational facts are shared, and prizes promoting healthy lifestyles are awarded. Led by a Diversity Navigator, the sessions include pre- and post-test surveys to assess knowledge gain and engagement. The intervention also connects participants with needed medical services.
Eligibility Criteria
You may qualify if:
- Age: Adults aged 18 years and above.
- Gender Identity: Individuals identifying as cisgender, transgender, or females.
- Language Proficiency: Proficiency in English equivalent to middle school/high school level.
- Registration: Completion of registration via the provided RedCap link prior to the Bingo session.
- Consent: Willingness to provide written consent at the beginning of the Bingo session to participate in the research study.
You may not qualify if:
- Age: Individuals under the age of 18 years.
- Gender Identity: Participants who do not identify as cisgender, transgender, or females.
- Language Proficiency: Inability to understand English at a middle school/high school level.
- Previous Participation: Individuals who have already participated in a previous Bingo game session for this study.
- Medical or Cognitive Impairment: Participants unable to provide informed consent or actively participate due to medical or cognitive reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Monali Vasekar, MD
Penn State Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine
Study Record Dates
First Submitted
July 11, 2024
First Posted
July 16, 2024
Study Start
October 28, 2024
Primary Completion
December 13, 2025
Study Completion
December 13, 2025
Last Updated
March 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Information will be collected in De identified manner . IPD will not be shared with any other researchers.